New treatment therapy shows promise for mesothelioma patients

A brand new mesothelioma treatment therapy tested in Australia has shown stunning results from its initial phase-one clinical trial.

One of the most difficult cancers to treat is the lung cancer mesothelioma. This type of cancer is specific to asbestos agents which are known to be the cause. Whether this is through repeated exposure over a longer period of time or massive inhalation over a shorter time frame, mesothelioma is very serious. Chemotherapy can in some cases slow down the progression of the disease, but there have not been many promising treatment studies in the last decade. That is until now. In June of 2015, a researcher in Australia may have found a groundbreaking new treatment therapy using nanocell delivery. One patient had such positive results, his mesothelioma is almost entirely gone based on PET scans.

Future in mesothelioma treatment through nanocell and microRNA technology

What has made mesothelioma difficult to treat is how it often responds to current cancer treating therapies, such as chemotherapy and radiation. With other types of lung cancers (non-asbestos related), masses can be distinct from surrounding lung tissue. These masses can be targeted with treatment and removed through surgery in many cases. Unfortunately, with mesothelioma, the cancer is in a way "meshed" with the healthy tissue, making it very difficult to pinpoint and then treat. That is where nanocell technology has become a game-changer for mesothelioma treatment research.

At the Asbestos Diseases Research Institute (ADRI) in Australia, associate professor and researcher Dr. Glen Reid, had been trying to utilize nanocells to deliver microRNA. These microRNAs are what can inhibit cancer growth. At first this therapy was tested on animals and then for the first time humans. Astoundingly, this initial trial showed great progress for one out of the ten patients tested. A plumber from Sydney, who was diagnosed in 2013 with mesothelioma, showed almost no signs of his tumors on PET scans after just two months.

Cautiously optimistic as more research and further studies must be performed

However, researchers are still cautiously optimistic with this new microRNA treatment therapy, as it has only gone through a phase-one clinical trial. The other nine patients either did not show signs of improvement or in fact, worsened. More trials must be conducted to provide further testing and data to confirm the long-lasting impact of microRNA treatment.

Taking action today towards compensation

While this new mesothelioma treatment therapy shows very promising results, it is still too early to tell if this is the cure for one of the most serious lung cancers. What can be done now is to evaluate potential legal action for the future of you and your family. Talk to an experienced injury attorney in Louisiana.